10 Healthcare Focused Hedge Funds and 10 Top Stock Picks
In this article, we discuss 10 healthcare focused hedge funds and 10 top stock picks.
Posts Tagged ‘Hedge Fund:307’
Top 10 Stocks Activist Investors Are Targeting
In this article we’re going to take a look at Top 10 Stocks Activist Investors Are Targeting in the recent weeks.
Top 5 Stocks Activist Investors Are Targeting
In this article, we’ll take a closer look at top 5 stocks activist investors are targeting.
Hedge Fund and Insider Trading News: Ken Griffin, Jim Simons, Cliff Asness, ARK36, Three Arrows Capital, Plains All American Pipeline, L.P. (PAA), Tricida, Inc. (TCDA), and More
Jim Simons discussed why his hedge fund employs scientists instead of bankers, defended Warren Buffett's relevance in an age of supercomputers and algorithmic trading, and shared...
15 Pharmaceutical Stocks to Buy According to Peter Kolchinsky’s RA Capital
In this piece, we will take a look at the top 15 pharmaceutical stocks to buy according to Peter Kolchinsky's RA Capital.
Hedge Fund and Insider Trading News: Millennium Management, RA Capital Management, Elliott Investment Management, Quantology Capital Management, QQM Fund Management, Akerna Corp (KERN), Alimentation Couche-Tard Inc (ANCUF), and More
Millennium Management sent a memo to staff telling them to disclose any personal trading in cryptocurrencies to the hedge fund giant’s compliance team.
Hedge Fund and Insider Trading News: John Paulson, Steve Cohen, RA Capital Management, Tiger Global Management, Norron Asset Management, Eastman Chemical Company (EMN), Ipsidy Inc (AUID), and More
Ever since John Paulson bet against the U.S. housing market more than a decade ago, people keep asking him about his next big trade.
RA Capital Management Bets Another $20 Million On Kala Pharmaceuticals Inc.
Peter Kolchinsky's RA Capital purchased $20 million of Kala Pharmaceuticals Inc. (KALA) shares.
This Biotech Investor’s Picks Returned 31% in Q1; Here Are Its New Bets
Peter Kolchinsky is one of the best biotech investors and many of his stock picks generate strong returns.
13D Filing: RA Capital Management and Biocryst Pharmaceuticals Inc (BCRX)
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
13D Filing: RA Capital Management and Solid Biosciences Inc (SLDB)
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
Big Insider Buying at Hot IPO Solid Biosciences (SLDB), Range Resources (RRC) and General Electric (GE)
With the stock market having been battered in recent days and fears that a large correction may be starting to pick up steam becoming more pronounced, investors are now in a position...
13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
13G Filing: RA Capital Management and Scpharmaceuticals Inc (SCPH)
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
13G Filing: RA Capital Management and Inflarx NV (IFRX)
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
13D Filing: RA Capital Management and Wave Life Sciences Ltd (WVE)
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
13G Filing: RA Capital Management and Sunesis Pharmaceuticals Inc (SNSS)
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
13D Filing: RA Capital Management and Kalvista Pharmaceuticals Inc. (KALV)
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)
You can access the original SEC filing by clicking here.
Avexis Inc. (AVXS): RA Capital Management Ups Its Stake
Peter Kolchinsky's RA Capital Management has slightly raised its stake in Avexis Inc. (NASDAQ:AVXS), as per a new Form 13G with the Securities and Exchange Commission.
RA Capital Management Slashes Alcobra Ltd (ADHD) Position After FDA Clinical Hold
Peter Kolchinsky's RA Capital Management has slashed its position in Alcobra Ltd (NASDAQ:ADHD) to just under 1.31 million shares according to a new 13G filing with the SEC.
Aclaris Therapeutics Inc (ACRS): RA Capital Management Disposes of 1.1 Million Shares
An amended 13G filing with the SEC revealed that Peter Kolchinsky's RA Capital Management has sold around 1.1 million shares of Aclaris Therapeutics Inc (NASDAQ:ACRS), decreasing...
Protagonist Therapeutics Inc (PTGX): RA Capital Management Acquires 6.8% Stake
Peter Kolchinsky's RA Capital Management reported via a recent 13G filing with the SEC that it has taken a new position in a company that has recently gone public, Protagonist...
RA Capital’s Top Q2 Performers; Predicts Big Things Ahead for Pharma Stocks
RA Capital Management LLC is a crossover fund manager that invests in public and private healthcare and life science companies developing drugs, medical devices and diagnostics...
Vitae Pharmaceuticals Inc (VTAE): RA Capital Management Ups Its Stake
A recent 13G filing with the SEC revealed that Peter Kolchinsky's RA Capital Management has acquired more shares of Vitae Pharmaceuticals Inc (NASDAQ:VTAE), as it currently...
Ardelyx (ARDX): RA Capital Management Boosts Stake to 7.7%
Peter Kolchinsky's RA Capital Management has stepped up its interest in Ardelyx Inc. (NASDAQ:ARDX).
Peter Kolchinsky Is Betting Big On Achillion Pharmaceuticals, Inc. (ACHN), Wave Life Sciences (WVE) & More Heading Into 2016
Peter Kolchinsky founded RA Capital Management in 2001 and focuses mainly on healthcare stocks.
13G Filing: RA Capital Management and Derma Sciences, Inc. (DSCI)
In a new filing with the Securities and Exchange Commission, Peter Kolchinsky's RA Capital Management disclosed a position in Derma Sciences Inc (NASDAQ:DSCI).
Dalton Investments Proposes 6-Point Action Plan to Eros, While Eminence Capital Reveals New Stake in This Hotel Operator
The practice of monitoring quarterly 13F filings has become more popular in recent years, which led to several exchange traded funds (ETFs) being launched.
Two Activist Plays And Two Biotech Moves You Should Check Out
With hedge funds having submitted their 13F filings for the third quarter, people at Insider Monkey are busy compiling the data necessary to identify the best investment opportunities...
Sequenom, Aclaris, and Xenoport Making Waves Among Elite Healthcare Investors
Three prominent healthcare-focused funds that we track at Insider Monkey submitted filings with the SEC today, disclosing new or bulked up positions in three different healthcare...
Is Zogenix A Good Stock To Buy Now?
RA Capital Management, led by Peter Kolchinsky, has disclosed a massive new stake in California-based pharmaceutical company Zogenix, Inc (NASDAQ:ZGNX).
Steve Cohen, Peter Kolchinsky Disclose New Stakes In Micro-cap Pharmaceutical Stocks
Steve Cohen’s Point72 Asset Management has initiated a new position in Inotek Pharmaceuticals Corporation (NASDAQ:ITEK).
Peter Kolchinsky’s New Top Healthcare Pick And Old Favorites
Peter Kolchinsky's RA Capital Management recently filed its 13F with the SEC for the reporting period of June 30.
RA Capital’s Latest Move In Alcobra Ltd (ADHD) Coming Off Hefty Second Quarter Gains
According to a recent filing with the Securities and Exchange Commission, Peter Kolchinsky's RA Capital has initiated a position in Alcobra Ltd (NASDAQ:ADHD), acquiring some 1...
RA Capital Is Expecting A Breakthrough Cardiovascular Drug From This Biotech
The biotechnology industry is up by more than 50% over the last year, but these towering returns don't come without great risk and volatility.
Ardelyx Inc (ARDX): RA Capital Management Discloses 7.3% Passive Stake
RA Capital Management, led by Peter Kolchinsky, has opened a new position in clinical-stage biopharmaceutical company Ardelyx Inc (NASDAQ:ARDX). A new filing with the U.S.
Bitauto Hldg Ltd (ADR) (BITA), Aurinia Pharmaceuticals Inc (AUPH): Tiger Global and RA Capital Disclose Their Latest Moves
In a new filing with the Securities and Exchange Commission, Billionaire Chase Coleman's Tiger Global disclosed slightly reducing its exposure to Bitauto Hldg Ltd (ADR) (NYSE...
Regulus Therapeutics Inc (RGLS), Trevena Inc (TRVN), Juno Therapeutics Inc (JUNO): RA Capital’s Top New Biotech Picks
Peter Kolchinsky’s RA Capital Management filed its latest 13F with the Securities and Exchange Commission in February, and we’ve gone through the data to highlight three of...
Tekmira Pharmaceuticals Corporation (TKMR): RA Capital Management Discloses 10% Passive Stake
It was revealed in a filing yesterday with the U.S Securities and Exchange Commission that RA Capital Management has opened a large, passive position in Tekmira Pharmaceuticals...
Synergy Pharmaceuticals Inc (SGYP), Proteon Therapeutics Inc (PRTO): James E. Flynn and Peter Kolchinsky Think These Stocks Look Healthy
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Proteon Therapeutics Inc (NASDAQ:PRTO) are in the spotlight as James E.
The Medicines Company (MDCO), TG Therapeutics Inc (TGTX): Bridger Management & Ra Capital Management Taking Plunge
In the last few days, we have seen a lot of capital from funds that we track getting shifted to pharmaceutical stocks and no it’s not just sector specific funds, but funds across...
CIG Wireless Corp (CIGW), Achillion Pharmaceuticals Inc (ACHN): Jeffrey Tannenbaum And Peter Kolchinsky Disclose Their Latest Moves
CIG Wireless Corp (OTCBB:CIGW), an operator of wireless and broadcast communication towers in the United States, has issued approximately 1.25 million shares to Jeffrey Tannenbaum...
Achillion Pharmaceuticals Inc (ACHN), Tenax Therapeutics Inc (TENX): Peter Kolchinsky’s Latest Equity Moves
RA Capital Management has continued the sale of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares.
Achillion Pharmaceuticals, Inc. (ACHN): RA Capital Management Sells Over 2 Million Shares
RA Capital Management, managed by Peter Kolchinsky, continues to unload its stake in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). In a new filing with the U.S.
Achillion Pharmaceuticals, Inc. (ACHN): Peter Kolchinsky’s RA Capital Sells Some More Shares
Peter Kolchinsky's RA Capital Management, in a new filing with the Securities and Exchange Commission, has disclosed the sale of around 1.70 million shares of Achillion Pharmaceuticals...
